Skip to content

Shattuck Labs, Inc. STTK Research and development contract costs

Research and development contract costs at other companies

Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$4.59M-52.5%
Geron logo
GeronGERN
$13M-5.1%
IQVIA logo
IQVIAIQV
$1.68B+8.0%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.49M+25.5%
CorMedix logo
CorMedixCRMD
$2.34M+113%
Adient logo
AdientADNT
$72M+2.9%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept sttk:AccruedResearchAndDevelopmentContractCostsCurrent.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s research and development contract costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s research and development contract costs?
Shattuck Labs, Inc. (STTK) reported research and development contract costs of $1.06M in Q1 2026.
What is the long-term trend for Shattuck Labs, Inc.'s research and development contract costs?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s research and development contract costs has grown at a -27.1% compound annual growth rate (CAGR), from $5.38M to $1.11M.
What does research and development contract costs mean?
This captures the short-term liabilities specifically related to outsourced research and development activities, such as clinical trial services or contract manufacturing. It represents the financial obligation for R&D work performed but not yet settled in cash. This is a critical indicator of the burn rate and the intensity of clinical development activities.